Rankings
▼
Calendar
VRDN Q2 2016 Earnings — Viridian Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VRDN
Viridian Therapeutics, Inc.
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$874,000
Gross Profit
$246,000
28.1% margin
Operating Income
-$2M
-284.2% margin
Net Income
-$3M
-286.8% margin
EPS (Diluted)
$-3.50
QoQ Revenue Growth
+6.8%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$635,000
Balance Sheet
Total Assets
$9M
Total Liabilities
$3M
Stockholders' Equity
$6M
Cash & Equivalents
$7M
← FY 2016
All Quarters
Q3 2016 →
